These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 33740437)
21. COVID-19 Vaccine in Children: Where Do We Stand?: Authors' Reply. Kasi SG; Shah A Indian Pediatr; 2021 Feb; 58(2):195. PubMed ID: 33632967 [No Abstract] [Full Text] [Related]
22. Using EM data to understand COVID-19 pathophysiology - Authors' reply. Dittmayer C; Meinhardt J; Radbruch H; Radke J; Heppner BI; Heppner FL; Stenzel W; Holland G; Laue M Lancet; 2021 Jan; 397(10270):197-198. PubMed ID: 33453781 [No Abstract] [Full Text] [Related]
23. Pregnancy Outcomes Among Women With and Without Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Adhikari EH; Moreno W; Zofkie AC; MacDonald L; McIntire DD; Collins RRJ; Spong CY JAMA Netw Open; 2020 Nov; 3(11):e2029256. PubMed ID: 33211113 [TBL] [Abstract][Full Text] [Related]
24. The Relationship Between Diabetes Mellitus and COVID-19 Prognosis: A Retrospective Cohort Study in Wuhan, China. Shang J; Wang Q; Zhang H; Wang X; Wan J; Yan Y; Gao Y; Cheng J; Li Z; Lin J Am J Med; 2021 Jan; 134(1):e6-e14. PubMed ID: 32653423 [TBL] [Abstract][Full Text] [Related]
25. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Zhang JJ; Dong X; Cao YY; Yuan YD; Yang YB; Yan YQ; Akdis CA; Gao YD Allergy; 2020 Jul; 75(7):1730-1741. PubMed ID: 32077115 [TBL] [Abstract][Full Text] [Related]
26. COVID-19 and the difficulty of inferring epidemiological parameters from clinical data - Authors' reply. Verity R; Okell L; Dorigatti I; Winskill P; Whittaker C; Walker P; Donnelly C; Ferguson N; Ghani A Lancet Infect Dis; 2021 Jan; 21(1):28. PubMed ID: 32473660 [No Abstract] [Full Text] [Related]
27. Preexisting prediabetes and the severity of COVID-19. Sathish T; Cao Y; Kapoor N Prim Care Diabetes; 2021 Feb; 15(1):28-29. PubMed ID: 32958435 [No Abstract] [Full Text] [Related]
28. Assessing the importance of interleukin-6 in COVID-19 - Authors' reply. Leisman DE; Ronner L; Pinotti R; Taylor MD; Sinha P; Calfee CS; Hirayama AV; Mastroianni F; Turtle CJ; Harhay MO; Legrand M; Deutschman CS Lancet Respir Med; 2021 Feb; 9(2):e14-e15. PubMed ID: 33460572 [No Abstract] [Full Text] [Related]
29. Reply to the letter of Singh and Singh in response to the article: "Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis" (Kumar et al.). Kumar A; Arora A; Sharma P; Anikhindi SA; Bansal N; Singla V; Khare S; Srivastava A Diabetes Metab Syndr; 2020; 14(5):1147-1148. PubMed ID: 32668400 [No Abstract] [Full Text] [Related]
30. SARS-CoV-2 and electrocardiography: is electrocardiography a predictor of mortality?-Authors' reply. Lanza GA; De Vita A Europace; 2021 Jul; 23(7):1151. PubMed ID: 34077534 [No Abstract] [Full Text] [Related]
31. Independent Impact of Diabetes on the Severity of Coronavirus Disease 2019 in 5,307 Patients in South Korea: A Nationwide Cohort Study (Diabetes Metab J 2020;44:737-46). Moon SJ; Rhee EJ; Lee WY; Yoon KH Diabetes Metab J; 2020 Dec; 44(6):942-943. PubMed ID: 33389963 [No Abstract] [Full Text] [Related]
32. Authors' Reply to: Errors in Tracing Coronavirus SARS-CoV-2 Transmission Using a Maximum Likelihood Tree. Comment on "A Snapshot of SARS-CoV-2 Genome Availability up to April 2020 and its Implications: Data Analysis". Mavian C; Marini S; Prosperi M; Salemi M JMIR Public Health Surveill; 2020 Nov; 6(4):e24661. PubMed ID: 33174844 [No Abstract] [Full Text] [Related]
34. Neutrophils as a pallbearer for SARS-CoV-2 disease burden - Authors' reply. Lutter R; Schurink B; Roos E; Guo L; van der Valk P; Bugiani M Lancet Microbe; 2021 Feb; 2(2):e57. PubMed ID: 33655232 [No Abstract] [Full Text] [Related]
35. Death by SARS-CoV 2: a Romanian COVID-19 multi-centre comorbidity study. Pantea Stoian A; Pricop-Jeckstadt M; Pana A; Ileanu BV; Schitea R; Geanta M; Catrinoiu D; Suceveanu AI; Serafinceanu C; Pituru S; Poiana C; Timar B; Nitipir C; Parvu S; Arsene A; Mazilu L; Toma A; Hainarosie R; Ceriello A; Rizzo M; Jinga V Sci Rep; 2020 Dec; 10(1):21613. PubMed ID: 33303885 [TBL] [Abstract][Full Text] [Related]
36. ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply. Voysey M; Pollard AJ Lancet; 2020 Nov; 396(10261):1486-1487. PubMed ID: 33160565 [No Abstract] [Full Text] [Related]
37. Rationale and evidence on the use of tocilizumab in COVID-19: A systematic review. Authors' reply. Cortegiani A; Ippolito M; Einav S Pulmonology; 2021; 27(1):87-88. PubMed ID: 33158787 [No Abstract] [Full Text] [Related]
38. Authors' reply to the comment "Treatment considerations for patients with pemphigus during the COVID-19 pandemic". Shakshouk H; Daneshpazhooh M; Murrell DF; Lehman JS J Am Acad Dermatol; 2021 Jan; 84(1):e61-e62. PubMed ID: 32896598 [No Abstract] [Full Text] [Related]
39. Differences of Severe Acute Respiratory Syndrome Coronavirus 2 Shedding Duration in Sputum and Nasopharyngeal Swab Specimens Among Adult Inpatients With Coronavirus Disease 2019. Wang K; Zhang X; Sun J; Ye J; Wang F; Hua J; Zhang H; Shi T; Li Q; Wu X Chest; 2020 Nov; 158(5):1876-1884. PubMed ID: 32569635 [TBL] [Abstract][Full Text] [Related]
40. COVID-19 and liver transplantation: the jury is still out - Authors' reply. Webb GJ; Marjot T; Barnes E; Barritt AS; Moon AM Lancet Gastroenterol Hepatol; 2021 Jan; 6(1):11. PubMed ID: 33137285 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]